GW&K Investment Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15
| Closed | – | – | 929 |
|
|
2023
Q4 | $0 | Sell |
15
-493,967
| -100% | – | ﹤0.01% | 932 |
|
|
2023
Q3 | $8.34M | Buy |
493,982
+5,237
| +1% | +$88.4K | 0.08% | 248 |
|
|
2023
Q2 | $6.71M | Sell |
488,745
-6,036
| -1% | -$82.8K | 0.06% | 254 |
|
|
2023
Q1 | $11.2M | Buy |
494,781
+15,122
| +3% | +$344K | 0.11% | 209 |
|
|
2022
Q4 | $11.3M | Sell |
479,659
-24,404
| -5% | -$574K | 0.11% | 206 |
|
|
2022
Q3 | $13.1M | Sell |
504,063
-12,234
| -2% | -$319K | 0.15% | 191 |
|
|
2022
Q2 | $11.3M | Sell |
516,297
-94,525
| -15% | -$2.07M | 0.12% | 202 |
|
|
2022
Q1 | $27.4M | Buy |
610,822
+530
| +0.1% | +$23.8K | 0.24% | 168 |
|
|
2021
Q4 | $26.2M | Buy |
610,292
+189,918
| +45% | +$8.14M | 0.22% | 173 |
|
|
2021
Q3 | $28M | Sell |
420,374
-2,393
| -0.6% | -$159K | 0.25% | 162 |
|
|
2021
Q2 | $31M | Buy |
422,767
+740
| +0.2% | +$54.3K | 0.27% | 161 |
|
|
2021
Q1 | $28.9M | Sell |
422,027
-30,364
| -7% | -$2.08M | 0.27% | 163 |
|
|
2020
Q4 | $30.4M | Buy |
452,391
+352,568
| +353% | +$23.7M | 0.32% | 146 |
|
|
2020
Q3 | $5.14M | Buy |
99,823
+13,020
| +15% | +$670K | 0.07% | 239 |
|
|
2020
Q2 | $3.27M | Buy |
+86,803
| New | +$3.27M | 0.05% | 259 |
|